ASX - By Stock
|
CMB |
Re:
New article
|
|
TILLI
|
20 |
7.4K |
2 |
07/03/16 |
07/03/16 |
ASX - By Stock
|
20
|
7.4K
|
2
|
|
ASX - By Stock
|
CMB |
Re:
New article
|
|
TILLI
|
20 |
7.4K |
4 |
04/03/16 |
04/03/16 |
ASX - By Stock
|
20
|
7.4K
|
4
|
|
ASX - By Stock
|
CMB |
Re:
manufacturing and development partner in Japan for its Progenza
|
|
TILLI
|
6 |
3.1K |
3 |
05/02/16 |
05/02/16 |
ASX - By Stock
|
6
|
3.1K
|
3
|
|
ASX - By Stock
|
CMB |
Re:
Ann: Appendix 4C - Quarterly
|
|
TILLI
|
6 |
1.9K |
2 |
04/02/16 |
04/02/16 |
ASX - By Stock
|
6
|
1.9K
|
2
|
|
ASX - By Stock
|
EHE |
Re:
A new star
|
|
TILLI
|
21 |
10K |
2 |
21/01/16 |
21/01/16 |
ASX - By Stock
|
21
|
10K
|
2
|
|
ASX - By Stock
|
CMB |
Re:
Ann: Presentation for Austrade Mission on Regenmed in Japan
|
|
TILLI
|
3 |
1.3K |
2 |
11/12/15 |
11/12/15 |
ASX - By Stock
|
3
|
1.3K
|
2
|
|
ASX - By Stock
|
CMB |
Re:
Ann: Patent granted for allogeneic stem cell technology platform
|
|
TILLI
|
18 |
6.3K |
0 |
17/11/15 |
17/11/15 |
ASX - By Stock
|
18
|
6.3K
|
0
|
|
ASX - By Stock
|
CMB |
Re:
Ann: Patent granted for allogeneic stem cell technology platform
|
|
TILLI
|
18 |
6.3K |
0 |
16/11/15 |
16/11/15 |
ASX - By Stock
|
18
|
6.3K
|
0
|
|
ASX - By Stock
|
CMB |
Re:
Ann: Patent granted for allogeneic stem cell technology platform
|
|
TILLI
|
18 |
6.3K |
2 |
11/11/15 |
11/11/15 |
ASX - By Stock
|
18
|
6.3K
|
2
|
|
ASX - By Stock
|
CMB |
Re:
Ann: Positive clinical results for CryoShot Equine
|
|
TILLI
|
4 |
1.3K |
0 |
05/11/15 |
05/11/15 |
ASX - By Stock
|
4
|
1.3K
|
0
|
|
ASX - By Stock
|
CMB |
Re:
Ann: Positive clinical results for CryoShot Equine
|
|
TILLI
|
4 |
1.3K |
1 |
05/11/15 |
05/11/15 |
ASX - By Stock
|
4
|
1.3K
|
1
|
|
ASX - By Stock
|
CMB |
Re:
Human Cancer Trials
|
|
TILLI
|
3 |
1.3K |
2 |
31/10/15 |
31/10/15 |
ASX - By Stock
|
3
|
1.3K
|
2
|
|
ASX - By Stock
|
CMB |
Re:
Ann: Regeneus receives R&D tax incentive refund of $3.4m
|
|
TILLI
|
5 |
1.7K |
1 |
14/10/15 |
14/10/15 |
ASX - By Stock
|
5
|
1.7K
|
1
|
|
ASX - By Stock
|
CMB |
Re:
Edison Report
|
|
TILLI
|
7 |
2.8K |
1 |
06/10/15 |
06/10/15 |
ASX - By Stock
|
7
|
2.8K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Van Leeuwenhoeck Institute initiates Research Coverage
|
|
TILLI
|
20 |
5.0K |
1 |
01/10/15 |
01/10/15 |
ASX - By Stock
|
20
|
5.0K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Van Leeuwenhoeck Institute initiates Research Coverage
|
|
TILLI
|
20 |
5.0K |
2 |
01/10/15 |
01/10/15 |
ASX - By Stock
|
20
|
5.0K
|
2
|
|
ASX - By Stock
|
NSR |
Re:
Boring but winning
|
|
TILLI
|
7 |
3.7K |
0 |
25/09/15 |
25/09/15 |
ASX - By Stock
|
7
|
3.7K
|
0
|
|
ASX - By Stock
|
TCL |
Re:
target raised
|
|
TILLI
|
10 |
4.0K |
1 |
22/09/15 |
22/09/15 |
ASX - By Stock
|
10
|
4.0K
|
1
|
|
ASX - By Stock
|
ALU |
Re:
Ann: Altium to Acquire Octopart
|
|
TILLI
|
27 |
13K |
2 |
18/09/15 |
18/09/15 |
ASX - By Stock
|
27
|
13K
|
2
|
|
ASX - By Stock
|
ALU |
Re:
Ann: Altium to Acquire Octopart
|
|
TILLI
|
27 |
13K |
0 |
18/09/15 |
18/09/15 |
ASX - By Stock
|
27
|
13K
|
0
|
|
ASX - By Stock
|
NSR |
Re:
Boring but winning
|
|
TILLI
|
7 |
3.7K |
0 |
18/09/15 |
18/09/15 |
ASX - By Stock
|
7
|
3.7K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
OSL SP potential
|
|
TILLI
|
11 |
4.0K |
2 |
16/09/15 |
16/09/15 |
ASX - By Stock
|
11
|
4.0K
|
2
|
|
ASX - By Stock
|
OSL |
Re:
News: OncoSil Medical's device scheduled for CE Mark Fast Track review
|
|
TILLI
|
17 |
5.9K |
6 |
11/09/15 |
11/09/15 |
ASX - By Stock
|
17
|
5.9K
|
6
|
|
ASX - By Stock
|
EHE |
Re:
A new star
|
|
TILLI
|
21 |
10K |
1 |
10/09/15 |
10/09/15 |
ASX - By Stock
|
21
|
10K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
Pivotal trial
|
|
TILLI
|
8 |
3.0K |
0 |
08/09/15 |
08/09/15 |
ASX - By Stock
|
8
|
3.0K
|
0
|
|
ASX - By Stock
|
OSL |
Pivotal trial
|
|
TILLI
|
8 |
3.0K |
0 |
06/09/15 |
06/09/15 |
ASX - By Stock
|
8
|
3.0K
|
0
|
|
ASX - By Stock
|
SKS |
Re:
Ann: Financial Results FY15
|
|
TILLI
|
6 |
2.0K |
0 |
26/08/15 |
26/08/15 |
ASX - By Stock
|
6
|
2.0K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
OSL 10 % DOWN...
|
|
TILLI
|
2 |
1.1K |
1 |
25/08/15 |
25/08/15 |
ASX - By Stock
|
2
|
1.1K
|
1
|
|
ASX - By Stock
|
CMB |
Re:
Red ,red,red....
|
|
TILLI
|
3 |
1.6K |
0 |
25/08/15 |
25/08/15 |
ASX - By Stock
|
3
|
1.6K
|
0
|
|
ASX - By Stock
|
THB |
Re:
Ann: Quarterly Cashflow Report
|
|
TILLI
|
4 |
1.8K |
1 |
04/08/15 |
04/08/15 |
ASX - By Stock
|
4
|
1.8K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
top pick in health sector
|
|
TILLI
|
13 |
7.2K |
1 |
02/08/15 |
02/08/15 |
ASX - By Stock
|
13
|
7.2K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
top pick in health sector
|
|
TILLI
|
13 |
7.2K |
4 |
30/07/15 |
30/07/15 |
ASX - By Stock
|
13
|
7.2K
|
4
|
|
ASX - By Stock
|
SKS |
Re:
Only to be read by owners of ENE
|
|
TILLI
|
28 |
8.2K |
1 |
23/07/15 |
23/07/15 |
ASX - By Stock
|
28
|
8.2K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
ce mark application must be close
|
|
TILLI
|
1 |
708 |
1 |
20/07/15 |
20/07/15 |
ASX - By Stock
|
1
|
708
|
1
|
|
ASX - By Stock
|
OSL |
Re:
Will liver sales be bigger than pancreatic $$$
|
|
TILLI
|
15 |
7.6K |
1 |
14/07/15 |
14/07/15 |
ASX - By Stock
|
15
|
7.6K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
naive
|
|
TILLI
|
1 |
894 |
4 |
09/07/15 |
09/07/15 |
ASX - By Stock
|
1
|
894
|
4
|
|
ASX - By Stock
|
IMM |
Re:
November
|
|
TILLI
|
19 |
6.3K |
2 |
03/11/14 |
03/11/14 |
ASX - By Stock
|
19
|
6.3K
|
2
|
|
ASX - By Stock
|
IMM |
Dilution
|
|
TILLI
|
24 |
7.8K |
11 |
22/10/14 |
22/10/14 |
ASX - By Stock
|
24
|
7.8K
|
11
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Appendix 4E & 2014 Full Year Statutory Accounts
|
|
TILLI
|
53 |
11K |
0 |
28/08/14 |
28/08/14 |
ASX - By Stock
|
53
|
11K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Accelerated approval
|
|
TILLI
|
10 |
3.4K |
2 |
22/08/14 |
22/08/14 |
ASX - By Stock
|
10
|
3.4K
|
2
|
|
ASX - By Stock
|
IMM |
Re:
Accelerated approval
|
|
TILLI
|
10 |
3.4K |
1 |
22/08/14 |
22/08/14 |
ASX - By Stock
|
10
|
3.4K
|
1
|
|
ASX - By Stock
|
IMM |
Re:
Accelerated approval
|
|
TILLI
|
10 |
3.4K |
1 |
22/08/14 |
22/08/14 |
ASX - By Stock
|
10
|
3.4K
|
1
|
|
ASX - By Stock
|
IMM |
Accelerated approval
|
|
TILLI
|
10 |
3.4K |
16 |
21/08/14 |
21/08/14 |
ASX - By Stock
|
10
|
3.4K
|
16
|
|
ASX - By Stock
|
IMM |
Re:
new announcent
|
|
TILLI
|
23 |
1.8K |
3 |
21/02/14 |
21/02/14 |
ASX - By Stock
|
23
|
1.8K
|
3
|
|
ASX - By Stock
|
IMM |
Re:
walking the dendreon path
|
|
TILLI
|
31 |
2.6K |
0 |
20/09/13 |
20/09/13 |
ASX - By Stock
|
31
|
2.6K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
rogers + roger = a wining combo
|
|
TILLI
|
18 |
1.6K |
5 |
20/09/13 |
20/09/13 |
ASX - By Stock
|
18
|
1.6K
|
5
|
|
ASX - By Stock
|
BNO |
Re:
starting to run
|
|
TILLI
|
45 |
6.3K |
0 |
19/09/13 |
19/09/13 |
ASX - By Stock
|
45
|
6.3K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Prima Files US Shelf Registration Statement
|
|
TILLI
|
54 |
2.4K |
0 |
29/08/13 |
29/08/13 |
ASX - By Stock
|
54
|
2.4K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
forward estimates
|
|
TILLI
|
9 |
485 |
1 |
13/08/13 |
13/08/13 |
ASX - By Stock
|
9
|
485
|
1
|
|
ASX - By Stock
|
IMM |
Re:
forward estimates
|
|
TILLI
|
9 |
485 |
0 |
13/08/13 |
13/08/13 |
ASX - By Stock
|
9
|
485
|
0
|
|